IP Library Granted Patent US 10,260,052
Granted Patent B2
US 10,260,052 · App. 15/120,952 · Granted Apr 16, 2019

Diacylgylcerol acyl transferase (DGA1) polynucleotides, and methods of increasing yeast cell lipid production by overexpression of heterologous DGA1

Inventors: Elena E. Brevnova (Belmont, MA); Arthur J. Shaw, IV (Belmont, MA); Emily H. Greenhagen (Melrose, MA)
Assignee: NOVOGY, INC.
C12N9/1029C12P7/6445C12Y203/0102
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,260,052
App. No.
15/120,952
Granted
Apr 16, 2019
Kind
B2
Abstract

DGA1 catalyzes the final enzymatic step for converting acyl-CoA and 1,2-diacylglycerol to triacylglycerols (TAG) and CoA in yeast. Disclosed are methods for expression in an oleaginous yeast host of polynucleotide sequences encoding DGA1 from Rhodosporidium toruloides, Lipomyces starkeyi, Aurantiochytrium limacinium, Aspergillus terreus , or Claviceps purpurea . Also described herein are engineered recombinant host cells of Yarrowia lipolytica comprising heterologous DGA1 polynucleotides encoding DGA1 proteins, or functionally active portions thereof, having the capability of producing increased lipid production and possessing the characteristic of enhanced glucose consumption efficiency.

Claims (7)

1. A method for producing a recombinant Yarrowia cell that has a higher lipid levels than a non-recombinant Yarrowia cell, the method comprising the steps of:

a) introducing into a Yarrowia cell a nucleic acid molecule encoding a heterologous polypeptide comprising SEQ ID NO: 9 or a biologically-active portion thereof; and

b) cultivating the recombinant Yarrowia cell, wherein the recombinant Yarrowia cell has a higher lipid content than a non-recombinant cell of the same species.

2. The method of claim 1 , wherein the yeast cell is Y. lipolytica.

3. The method of claim 1 , wherein the polynucleotide has at least 95% sequence identity to SEQ ID NO: 10.

4. The method of claim 1 , wherein the polypeptide has at least 90% sequence identity to SEQ ID NO: 9.

5. The method of claim 1 wherein the biologically active portion is a 278 contiguous amino acids of SEQ ID NO:9.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 054142 FRAME: 0171. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Nov 17, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 054451/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC
Reel/Frame 054142/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2017
From: BREVNOVA, ELENA E.; SHAW, ARTHUR J.; GREENHAGEN, EMILY H.
To: NOVOGY, INC.
Reel/Frame 041968/0601 →
Continuity (2)
Provisional Application 61943664 · Feb 24, 2014
Related Publication 20160362663A1 · Dec 15, 2016